Follow the Medicamen Biotech Limited stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Medicamen Biotech Limited has logged 30 reports. Market capitalisation: €3.2bn. The latest transaction was disclosed on 24 September 2025 (Sale). Among the most active insiders: Geetika Madan. The full history is free.
30
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
€3m
23 ops.
Sell Volume
10Σ signal
Buys €1m€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,908 of 29,064 companies
42.2
score / 100
Value
33
Quality
52
FCF yld-12%
Earn yld3.0%
EV/EBITDA16.1x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.